2024-04-25 | Sale | Cytokinetics, Incorporated CYTK | director | 10,562 0.0099% | $64.54 | $681,671 | -16.42% | |
2024-02-14 | Sale | Cytokinetics, Incorporated CYTK | director | 5,000 0.0049% | $76.48 | $382,400 | -14.68% | |
2024-01-12 | Sale | Cytokinetics, Incorporated CYTK | director | 5,000 0.0051% | $85.14 | $425,700 | -21.78% | |
2023-12-18 | Sale | Cytokinetics, Incorporated CYTK | director | 2,458 0.0025% | $36.34 | $89,324 | +85.58% | |
2023-05-15 | Sale | Cytokinetics, Incorporated CYTK | director | 4,166 0.0042% | $37.77 | $157,350 | -6.75% | |
2022-09-12 | Sale | Cytokinetics, Incorporated CYTK | director | 21,759 0.0234% | $54.95 | $1.2M | -29.62% | |
2021-11-05 | Sale | Cytokinetics, Incorporated CYTK | director | 8,503 0.0098% | $40.00 | $340,120 | -1.9% | |
2021-04-01 | Sale | Cytokinetics, Incorporated CYTK | director | 2,233 0.003% | $23.66 | $52,833 | +35.15% | |
2020-12-31 | Sale | Cytokinetics, Incorporated CYTK | director | 858 0.0012% | $20.31 | $17,426 | +23.32% | |
2020-10-05 | Sale | Cytokinetics, Incorporated CYTK | director | 3,000 0.0047% | $29.00 | $87,000 | -22.61% | |
2019-11-19 | Cytokinetics, Incorporated CYTK | director | 6,000 0.0097% | $8.57 | $51,427 | +75.35% | ||
2019-11-07 | Myriad Genetics, Inc. MYGN | director | 14,000 0.0188% | $23.46 | $328,446 | -38.53% | ||
2018-07-11 | Sale | Myriad Genetics, Inc. MYGN | director | 40,000 0.0479% | $37.64 | $1.51M | -25.91% | |
2017-09-01 | Sale | Myriad Genetics, Inc. MYGN | director | 40,000 0.0517% | $26.84 | $1.07M | +13.85% | |
2017-02-23 | Myriad Genetics, Inc. MYGN | director | 8,000 0.0115% | $18.58 | $148,634 | +51.97% | ||
2017-02-22 | Myriad Genetics, Inc. MYGN | director | 4,000 0.0059% | $18.81 | $75,226 | +53.56% | ||
2016-09-12 | Sale | Myriad Genetics, Inc. MYGN | director | 4,014 0.0056% | $20.21 | $81,136 | -7.52% | |
2016-09-09 | Sale | Myriad Genetics, Inc. MYGN | director | 55,986 0.0624% | $15.56 | $870,974 | -4.68% | |
2014-06-05 | Sale | Myriad Genetics, Inc. MYGN | director | 10,000 0.0081% | $21.65 | $216,511 | +2.2% | |
2014-03-07 | Sale | Myriad Genetics, Inc. MYGN | director | 40,000 0.0323% | $22.73 | $909,196 | -4.01% |